Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Julie Hjerpsted"'
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate whether the pharmacokinetic characteristics of semaglutide were altered in people with hepatic impairment, assessed using Child-Pugh criteria, vs those with normal hepatic function. Methods In this multicentre, open-label, paralle
Publikováno v:
Diabetes, Obesity & Metabolism
Aim: To investigate the effects of semaglutide on fasting and postprandial glucose and lipid responses, and on gastric emptying. Materials and Methods: This was a randomised, double-blind, placebo-controlled, two-period, crossover trial. Subjects wit
Publikováno v:
Journal of Nutrition & Intermediary Metabolism, Vol 3, Iss C, Pp 12-17 (2016)
Hjerpsted, J B, Dragsted, L O & Tholstrup, T 2016, ' Cheese intake lowers plasma cholesterol concentrations without increasing bile acid excretion ', Journal of Nutrition & Intermediary Metabolism, vol. 3, no. 1, pp. 12-17 . https://doi.org/10.1016/j.jnim.2015.11.002
Hjerpsted, J B, Dragsted, L O & Tholstrup, T 2016, ' Cheese intake lowers plasma cholesterol concentrations without increasing bile acid excretion ', Journal of Nutrition & Intermediary Metabolism, vol. 3, no. 1, pp. 12-17 . https://doi.org/10.1016/j.jnim.2015.11.002
Purpose Cheese is a dairy product with high calcium content. It has been suggested that calcium intake may increase fecal excretion of bile acids that would cause a regeneration of bile acids from hepatic cholesterol and thereby result in a lowering
Effect of cheese and butter intake on metabolites in urine using an untargeted metabolomics approach
Publikováno v:
Metabolomics. 10:1176-1185
Cheese intake has been shown to decrease total cholesterol and LDL cholesterol concentrations when compared to butter of equal fat content. An untargeted metabolite profiling may reveal exposure markers of cheese but may also contribute with markers
Autor:
Julie Hjerpsted, Catherine Gibbons, Graham Finlayson, Mads Axelsen, Trine Kvist, Anne Flint, John E. Blundell
Publikováno v:
Diabetes, Obesity & Metabolism
Aim The aim of this trial was to investigate the mechanism of action for body weight loss with semaglutide. Materials and methods This randomised, double-blind, placebo-controlled, two-period crossover trial investigated the effects of 12 weeks of tr
Publikováno v:
The American Journal of Clinical Nutrition. 94:1479-1484
Background: Despite its high content of saturated fatty acids, cheese does not seem to increase plasma total and LDL-cholesterol concentrations when compared with an equivalent intake of fat from butter. This effect may be due to the high calcium con
Autor:
Julie Hjerpsted, Tine Tholstrup
Publikováno v:
Critical reviews in food science and nutrition. 56(8)
Currently, the effect of dairy products on cardiovascular risk is a topic much debated and with conflicting results. The purpose of this review is to give an overview of the existing literature regarding the effect of cheese intake and risk of cardio
Autor:
John E. Blundell, Bertrand Cariou, Graham Finlayson, Julie Hjerpsted, Trine Kvist, A. Bouzidi, Anne Flint, Catherine Gibbons, Mads Axelsen
Publikováno v:
Diabetes & Metabolism. 43:A110
Autor:
Julie Hjerpsted, A. Bouzidi, Mads Axelsen, Trine Kvist, Anne Flint, Ashley Brooks, Bruno Vergès, John E. Blundell
Publikováno v:
Diabetes & Metabolism. 43:A109
Autor:
Mads Axelsen, Trine Kvist, Anne Flint, John E. Blundell, Julie Hjerpsted, Eirik Quamme Bergan, Catherine Gibbons, Graham Finlayson
Publikováno v:
Canadian Journal of Diabetes. 40:S3
Introduction: Glucagon-like peptide-1 (GLP-1) therapy has thepotential to decrease body weight. Semaglutide is a human GLP-1analogue.Methods: This 12 week double-blind, crossover study examinedthe mechanisms of weight loss with once-weekly subcutaneo